PYRIDINYL-(AZA)INDOLSULFONAMIDE
European patent · EP4074703 · Deleted
Register entry
- Publication number
- EP4074703
- Application number
- EP22171413
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Jun 18, 2019
- Published
- Oct 19, 2022
- Granted
- Nov 29, 2023
- Deleted
- Jan 27, 2026
- Reason
- Annual fee unpaid
- IPC classes
- C07D 401/12 (2006.01)C07D 471/04 (2006.01)A61P 25/00 (2006.01)A61K 31/404 (2006.01)A61K 31/4439 (2006.01)C07D 403/12 (2006.01)
- Priority
- EP 18178429 19.06.2018EP 19157936 19.02.2019
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jan 27, 2026
Deleted, fee unpaid
- Status of protective title
- Active → Cancelled
- Cancellation date
- 27.01.2026
- Cause for cancellation
- Non-payment of renewal fee
Published in Swissreg on 27.01.2026
- Oct 9, 2024
Change
Published in Swissreg on 09.10.2024
- Jul 1, 2024
Change
Published in Swissreg on 01.07.2024
- Mar 6, 2024
Owner
- Owner
- UCB Pharma GmbH, Alfred-Nobel-Strasse 10, 40789 Monheim, Germany → UCB Pharma GmbH, Rolf-Schwarz-Schütte-Platz 1, 40789 Monheim am Rhein, Germany
Published in Swissreg on 06.03.2024
- Nov 29, 2023
Granted
Published in Swissreg on 29.11.2023
Parties
Inventor
MUELLER, Christa E.
53113 Bonn, DE
BOSHTA, Nader
53115 Bonn, DE
EL-TAYEB, Ali
53115 Bonn, DE
PEGURIER, Cécile
1070 Brussels, BE
CARDENAS, Alvaro
1070 Brussels, BE
PROVINS, Laurent
1070 Brussels, BE
LEDECQ, Marie
1070 Brussels, BE
HOCKEMEYER, Joerg
53113 Bonn, DE
RASHED, Mahmoud
11884 Cairo, EG
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.